Skip to main content

Published locations for Poziotinib provides ‘modest but meaningful’ efficacy in NSCLC subgroup

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Poziotinib provides ‘modest but meaningful’ efficacy in NSCLC subgroup

User login

  • Reset your password
  • /content/poziotinib-provides-modest-meaningful-efficacy-nsclc-subgroup
  • /oncologypractice/article/223132/lung-cancer/poziotinib-provides-modest-meaningful-efficacy-nsclc
  • /hematology-oncology/article/223132/lung-cancer/poziotinib-provides-modest-meaningful-efficacy-nsclc
  • /chestphysician/article/223132/lung-cancer/poziotinib-provides-modest-meaningful-efficacy-nsclc